Expression reduced in cisplatin-resistant BC, SLC7A11 up-regulated, and GSH biosynthesis increased, promoting cisplatin resistance[81]; associated with radiotherapy and cisplatin therapy[26]; rs11671784 A replaced by G, reducing the chemical sensitivity[80]. This evidence concerns the gene SLC7A11 and breast cancer.